Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cardiovascular Implications of the Covid-19: Management of Complications and Drug Safety Concerns Publisher



Hamidian M1 ; Ansari R2 ; Zarshenas MM3, 4 ; Foroughinia F1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  4. 4. Department of Phytopharmaceuticals (Traditional Pharmacy), School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

Source: Journal of Research in Medical Sciences Published:2022


Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has rapidly spread worldwide and has been infected more than 219 million individuals with 4.55 million deaths worldwide as of September 2021, causing a pandemic. Preexisting cardiovascular (CV) comorbidities such as hypertension, diabetes, and coronary artery disease seem to be associated with greater severity of infection, worse prognosis, and higher mortality. Moreover, COVID-19 can contribute to CV complications, including acute myocardial injury, arrhythmia, acute coronary syndrome, and venous thromboembolism, emphasizing the importance of precocious detection and implementation of optimal therapeutic strategies. This review provides an overview of evidence-based data of CV complications of COVID-19, focusing on their management strategies, as well as potential cardiac adverse effects and drug interactions, due to off-label and investigational drugs used for the treatment of COVID-19. © 2022 Journal of Research in Medical Sciences.
Related Docs
View other Related Docs
1. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
2. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
3. Anticoagulant Therapy in Covid-19: A Narrative Review, Clinical and Translational Science (2023)
4. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
5. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
6. Pharmacotherapy Consideration of Thrombolytic Medications in Covid-19-Associated Ards, Journal of Intensive Care (2022)
7. Venous Thromboembolism in Viral Diseases: A Comprehensive Literature Review, Health Science Reports (2023)
8. Cardiovascular Complications of Covid-19: Pharmacotherapy Perspective, Cardiovascular Drugs and Therapy (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (11)
Hossein Khalili (10)
Other Related Docs
9. Effect of Intermediate-Dose Vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With Covid-19 Admitted to the Intensive Care Unit: The Inspiration Randomized Clinical Trial, JAMA - Journal of the American Medical Association (2021)
10. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
11. Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments, Cardiology in Review (2022)
12. Thrombotic Storm in Coronavirus Disease 2019: From Underlying Mechanisms to Its Management, Journal of Medical Microbiology (2022)
13. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
14. Covid-19: A Review on Treatment Strategies and Candidate Vaccines, Scientific Journal of Kurdistan University of Medical Sciences (2021)
15. Effect of Covid-19 Medications on Corrected Qt Interval and Induction of Torsade De Pointes: Results of a Multicenter National Survey, International Journal of Clinical Practice (2021)
16. Investigating Lipid-Modulating Agents for Prevention or Treatment of Covid-19: Jacc State-Of-The-Art Review, Journal of the American College of Cardiology (2021)
17. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
18. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
19. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
20. Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients With Covid-19: Insights Into New Sars-Cov-2 Variants, Vaccination Status, and Emerging Oral Antivirals, Thrombosis and Haemostasis (2023)
21. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
22. Post-Discharge Thromboembolic Events in Covid-19 Patients: A Review on the Necessity for Prophylaxis, Clinical and Applied Thrombosis/Hemostasis (2023)
23. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
24. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
25. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
26. Coagulopathy: Another Side Effect of Coronavirus Infection, Journal of Cardiovascular and Thoracic Research (2021)
27. Nanotheranostics Against Covid-19: From Multivalent to Immune-Targeted Materials, Journal of Controlled Release (2020)
28. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
29. Ischemic Gastrointestinal Complications of Covid-19: A Systematic Review on Imaging Presentation, Clinical Imaging (2021)
30. Atorvastatin Versus Placebo in Patients With Covid-19 in Intensive Care: Randomized Controlled Trial, The BMJ (2022)
31. Antiviral Optical Techniques As a Possible Novel Approach to Covid-19 Treatment, Journal of Innovative Optical Health Sciences (2021)
32. Case Report: Covid-19-Associated Rhinosinusitis Mucormycosis Caused by Rhizopus Arrhizus: A Rare But Potentially Fatal Infection Occurring After Treatment With Corticosteroids, American Journal of Tropical Medicine and Hygiene (2021)
33. Can Anti-Parasitic Drugs Help Control Covid-19?, Future Virology (2022)
34. How to Overcome Cardiovascular Challenges in Covid-19 Patients: A Guide for Common Practice, Acta Biomedica (2020)
35. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)
36. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
37. Corona and Misery: Sixth Epidemiologic Transition by Covid-19 and Its Consequent Cardiovascular Complications, Journal of Iranian Medical Council (2022)
38. Recent Randomized Trials of Antithrombotic Therapy for Patients With Covid-19: Jacc State-Of-The-Art Review, Journal of the American College of Cardiology (2021)
39. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
40. Intermediate-Dose Versus Standard-Dose Prophylactic Anticoagulation in Patients With Covid-19 Admitted to the Intensive Care Unit: 90-Day Results From the Inspiration Randomized Trial, Thrombosis and Haemostasis (2021)
41. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
42. Covid-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment, Seminars in Thrombosis and Hemostasis (2023)
43. Covid-19 Associated Thrombotic Thrombocytopenic Purpura (Ttp); a Case Series and Mini-Review, International Immunopharmacology (2021)
44. A Narrative Review on Adverse Drug Reactions of Covid-19 Treatments on the Kidney, Open Medicine (Poland) (2024)
45. Coagulopathy and Thromboembolic Events a Pathogenic Mechanism of Covid-19 Associated With Mortality: An Updated Review, Journal of Clinical Laboratory Analysis (2023)
46. Cardiovascular Disease in Covid-19: A Systematic Review and Meta-Analysis of 10,898 Patients and Proposal of a Triage Risk Stratification Tool, Egyptian Heart Journal (2020)
47. Pharmacotherapeutic Considerations in Solid Organ Transplant Patients With Covid-19, Expert Opinion on Pharmacotherapy (2020)
48. Investigation of Effective Drugs in the Treatment of Patients With Covid-19, Journal of Iranian Medical Council (2023)
49. Covid-19 Infection and Liver Injury: Clinical Features, Biomarkers, Potential Mechanisms, Treatment, and Management Challenges, World Journal of Clinical Cases (2021)
50. Characteristics of Published/Registered Clinical Trials on Covid-19 Treatment: A Systematic Review, DARU# Journal of Pharmaceutical Sciences (2021)